Literature DB >> 963686

Integration of chemotherapy into combined modality treatment of solid tumors VII. Adenocarcinoma of the breast.

S K Carter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 963686     DOI: 10.1016/s0305-7372(76)80020-5

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  31 in total

Review 1.  Systemic therapy of advanced breast cancer.

Authors:  H T Mouridsen
Journal:  Drugs       Date:  1992       Impact factor: 9.546

2.  The "new" era of oral antineoplastic drug therapy: revisiting "old" concerns.

Authors:  Maurie Markman
Journal:  Curr Oncol Rep       Date:  2006-09       Impact factor: 5.075

Review 3.  [Current status in the treatment of breast cancer. I. Endocrine management--change of concepts and outlook for the future (author's transl)].

Authors:  U Jehn; H Sauer; W Wilmanns
Journal:  Klin Wochenschr       Date:  1979-09-17

Review 4.  Adjuvant chemotherapy in breast cancer: critique and perspectives.

Authors:  S K Carter
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

5.  Mitoxantrone: an overview of safety and toxicity.

Authors:  L E Posner; G Dukart; J Goldberg; T Bernstein; K Cartwright
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

6.  Comparison of 5-fluorouracil anabolite levels after intravenous bolus and continuous infusion.

Authors:  T A Stein; B Bailey; G P Burns
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

7.  Vindesine in the treatment of breast cancer.

Authors:  I E Smith; T J Powles
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

8.  Mitoxantrone as a first-line treatment of advanced breast cancer.

Authors:  K Landys; S Borgstrom; T Andersson; H Noppa
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

Review 9.  Mammary cancers and pregnancy.

Authors:  J M Anderson
Journal:  Br Med J       Date:  1979-04-28

10.  Prednimustine in combination with methotrexate and 5-fluorouracil in advanced breast cancer: a phase I-II study.

Authors:  H T Mouridsen; E Boesen
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.